Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IRAG1 antisense RNA 1 (non-protein coding) (IRAG1-AS1)
- Target
- IRAG1-AS1
- Molecular classification
- Other (long non-coding RNA, antisense RNA)
01
Overview
IRAG1 antisense RNA 1 (IRAG1-AS1) is a long non-coding antisense RNA transcribed from the region complementary to the IRAG1 gene locus. Its primary function is believed to be the regulation of the protein-coding gene IRAG1 through antisense mechanisms, which may include altering chromatin structure, affecting transcription, stability, or translation of the target mRNA. Antisense RNAs are increasingly recognized as important gene regulators, influencing gene expression at multiple levels and contributing to fine-tuning physiological and pathological processes. While some antisense RNAs have clear disease relevance, IRAG1-AS1’s clinical relevance is not yet defined[2][4].
- Other names
- MRVI1 antisense RNA 1MRVI1-AS1IRAG1-AS1IRAG1 antisense RNA 1 (non-protein coding)
02
Mechanism of action
Not applicable (not a therapeutic target, but as an antisense RNA it would regulate gene expression through molecular hybridization, chromatin modification, or transcription interference[2])
03
Biological functions
Regulation of gene expression (specifically, regulation of the IRAG1 gene)Epigenetic regulation (may regulate chromatin structure and transcriptional activity in cis or trans)
04
Disease associations
Other (no direct, established association with a particular disease, but dysregulation of antisense RNAs can be involved in pathological processes; as of current data, specific roles in cancer or other diseases for IRAG1-AS1 have not been well-characterized)
Beyond the preview
Go deeper on IRAG1 antisense RNA 1 (non-protein coding) (IRAG1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IRAG1 antisense RNA 1 (non-protein coding) (IRAG1-AS1).